EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Recent progress in application of nanovaccines for enhancing mucosal immune responses

Guangsheng Du, Ming Qin, Xun Sun

Acta Pharmaceutica Sinica B · 2023-06 · 13 (6) · 2334-2345

DOI: 10.1016/j.apsb.2022.08.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-06. Verfasst von Guangsheng Du und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal vaccines that stimulate both mucosal and systemic immune responses are desirable, as they could prevent the invading pathogens at their initial infection sites in a convenient and user-friendly way. Nanovaccines are receiving increasing attention for mucosal vaccination due to their merits in overcoming mucosal immune barriers and in enhancing immunogenicity of the encapsulated antigens. Herein, we summarized several nanovaccine strategies that have been reported for enhancing mucosal immune responses, including designing nanovaccines that have superior mucoadhesion and mucus penetration capacity, designing nanovaccines with better targeting efficiency to M cells or antigen-presenting cells, and co-delivering adjuvants by using nanovaccines. The reported applications of mucosal nanovaccines were also briefly discussed, including prevention of infectious diseases, and treatment of tumors and autoimmune diseases. Future research progresses in mucosal nanovaccines may promote the clinical translation and application of mucosal vaccines.

Schlagwörter

Stichwörter der Autor:innen

AdjuvantsCell targetingInfectious diseasesM cellsMucosal immune systemMucosal vaccinesMucus adhesion and penetrationNanovaccines

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Sichuan University
  • Fundamental Research Funds for the Central Universities
  • Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System

Zitieren

APA

Du, G., Qin, M., & Sun, X. (2023). Recent progress in application of nanovaccines for enhancing mucosal immune responses. Acta Pharmaceutica Sinica B, 13(6), 2334-2345. https://doi.org/10.1016/j.apsb.2022.08.010

Vancouver

Du G, Qin M, Sun X. Recent progress in application of nanovaccines for enhancing mucosal immune responses. Acta Pharmaceutica Sinica B. 2023;13(6):2334-2345. doi:10.1016/j.apsb.2022.08.010

BibTeX
@article{Du2023,
  author = {Du, Guangsheng and Qin, Ming and Sun, Xun},
  title = {Recent progress in application of nanovaccines for enhancing mucosal immune responses},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {6},
  pages = {2334--2345},
  doi = {10.1016/j.apsb.2022.08.010}
}
Kostenlos starten →